![](/img/cover-not-exists.png)
Liraglutide 3.0mg improves body weight and cardiometabolic risk factors in overweight or obese adults without diabetes: The SCALE Obesity and Prediabetes randomised, double-blind, placebo-controlled 56-week trial
Wittert, Gary, le Roux, Carel W., Astrup, Arne, Fujioka, Ken, Greenway, Frank, Halpern, Alfredo, Lau, David C.W., Ortiz, Rafael Violante, Wilding, John, Furber, Sabina, Lilleøre, Søren Kruse, Pi-SunyeVolume:
8
Language:
english
Journal:
Obesity Research & Clinical Practice
DOI:
10.1016/j.orcp.2014.10.211
Date:
December, 2014
File:
PDF, 54 KB
english, 2014